1 / 20

Women in treatment in the Czech Republic

Women in treatment in the Czech Republic. Běla Studničková, M. D. , Vladimír Polanecký, M. D. Drug Epidemiology Headquarters Hygienic Station of the Capital Prague. Women in treatment in the Czech Republic. System of data collection. Data provider = TC centres

vivek
Download Presentation

Women in treatment in the Czech Republic

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Women in treatment in the Czech Republic Běla Studničková, M. D., Vladimír Polanecký, M. D. Drug Epidemiology Headquarters Hygienic Station of the Capital Prague

  2. Women in treatment in the Czech Republic System of data collection • Data provider = TC centres • Data collection provides Hygienic Service • National sumary of data and data analysis provides Drug Epidemiology Headquarters of the Hygienic Station of the Capital Prague • EMCDDA form is used • monitoring of incidence of treated drug users (First Treatment Demand – FTD) since 1.1.1995 • monitoring of prevalence of treated drug users and All Treatment Demand (ATD) since 1.1.2002

  3. Women in treatment in the Czech Republic Collected data: • Age • Sex • District of T/C • District of living • Source of referral • Current living status • Employment status • Highest education level • Primary and secondary drugs • Route of Administration • Frequency of use • Duration of regular use • Risk behaviour: • Curently or ever injected • Shared past month or ever • HIV and VH status • Initial outcome

  4. Women in treatment in the Czech Republic - 2003The age distributionof treated drug users according to sex Prevalence in the year 2003 Incidence (FTD)in the year 2003

  5. Women in treatment in the Czech Republic - 2003The age distributionof treated heroin and Pervitin usersaccording to sex All Pervitin users in the Czech Republic in the year 2003 (Prevalence) All Pervitin users in Prague in the year 2003 (Prevalence)

  6. Women in treatment in the Czech Republic 1995 – 2003Trends of the number and of the share of first treated men and women

  7. Women in treatment in the Czech Republic - 2003The share of men and women according to groups of primary drug

  8. Women in treatment in the Czech Republic – 2003 Groups of primary drug according to sex

  9. Women in treatment in the Czech Republic, 1995 - 2003 Number of first treated women with drug useaccording to groups of primary drug

  10. Women in treatment in the Czech Republic – 2003Treated drug users according to the age

  11. Women in treatment in the Czech Republic – 2003Treated drug users according to the labour status and sex

  12. Women in treatment in the Czech Republic - 2003The number of women and the share of primary drugs according to age groups

  13. Women in treatment in the Czech Republic, 1995 - 2003 First treated women with drug useaccording to age groups

  14. Women in treatment in the Czech Republic – 2003Groups of primary drug according to regions - Prevalence

  15. Women in treatment in the Czech Republic – 2003Groups of primary drug according to regions - FTD

  16. Women in treatment in the Czech Republic – 2003 Average age of treated clients according to sex

  17. Women in treatment in the Czech Republic – 2003Route of administration of primary drug according to sex

  18. Women in treatment in the Czech Republic – 2003Primary and secondary drugs used by women Prevalence FTD

  19. Women in treatment in the Czech RepublicCONCLUSIONS: • The highest number of treated women is in the age group 15 – 19 years • The men : women ratio is lowest in both youngest age groups, in pervitin users in the Czech Republic is lower then 1 : 1 (in Prague in 3 youngest age groups) • The trend of number of treated women is still increasing • Treated women use pervitin more often then men • Treated women are younger then men (55 % of all treated women are younger then 20 years) and they are more commonly in category „pupil / student“ • The share of pervitin use and heroin use among women grows with older age group; the share of cannabinoids use decreases • The average age of treated women using heroin and opiates is about two years lower in comparison with men, in pervitin the difference is 3,5 years • The share of treated women with inject administration of drug is about 4 % higher in comparison with men

  20. Thanks for your attention!

More Related